Researchers are adapting a treatment from the 1918 flu pandemic — transferring antibodies from the blood of recovered patients — to help those with COVID-19. It's a stopgap that could be especially critical for first responders. (hereandnow)
A group of researchers in the U.S. say they're close to releasing a treatment that could help patients infected with the coronavirus. It's one that was used successfully during the flu pandemic on 1918.
It’s a treatment that was used during the 1918 influenza pandemic involving the use of blood from recovered flu patients. And now Dr. Peter Hotez, a professor of virology and microbiology at Baylor College of Medicine in Texas, is promoting convalescent serum antibody treatment to save especially first responders who are treating patients infected with coronavirus.
Isolating the antibodies is important, so there is no risk of actually injecting people with the virus, Hotez says. There is a risk of potential lung injury, but that is uncommon.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Carney Hospital In Dorchester To Be Nation's First Dedicated COVID-19 HospitalA Boston hospital is being turned into a 135-bed facility for COVID-19 patients. Its parent company, Steward Health Care, hopes it can be a model for more centers nationwide, allowing for focused care and freeing up ER resources. WBUR
続きを読む »
Some health officials enforcing court orders against rogue COVID-19 patients
続きを読む »
Patients with breathing, lung problems at highest risk with COVID-19 - studyPatients with existing illnesses that cause breathlessness, wheezing or lung pro...
続きを読む »
Coronavirus Drug Update: The Latest Info On Pharmaceutical Treatments And VaccinesForbes is tracking a definitive list of the pharmaceutical companies and startups working to find treatments and vaccines for the COVID-19 coronavirus.
続きを読む »
Are U.S. Hospitals Ready?Here's what it will take for medical facilities across the nation to handle the coming surge of COVID-19 patients.
続きを読む »